Ziyuanyuan Holdings Group Limited provided unaudited consolidated earnings guidance for the year ended 31 December 2022. The group is expected to record a significant increase in profit attributable to owners of the Company for the Reporting Period by not less than 100% as compared with that for the year ended 31 December 2021 of approximately RMB 5.5 million. The expected increase in profit attributable to owners of the Company was mainly attributable to the strong growth in overall revenue with an expected increase of not less than 150%, of which revenue from the trading of medical equipment and consumables business continued its strong growth, substantially increased as compared with the corresponding period in 2021.
Ziyuanyuan Holdings Group Limited
Equities
8223
KYG9898B1041
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 HKD | -1.88% | -7.65% | -13.74% |
1st Jan change | Capi. | |
---|---|---|
-13.74% | 88.03M | |
-4.85% | 182B | |
+0.19% | 110B | |
-3.93% | 67.92B | |
+2.14% | 50.96B | |
+9.55% | 44.7B | |
+2.70% | 40.66B | |
+21.93% | 27.6B | |
+4.09% | 26.63B | |
-0.39% | 24.98B |
- Stock Market
- Equities
- 8223 Stock
- News Ziyuanyuan Holdings Group Limited
- Ziyuanyuan Holdings Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022